Legal & General Group Plc - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,543
-24.0%
5,0660.0%0.00%
Q4 2022$5,978
-84.3%
5,0660.0%0.00%
Q3 2022$38,000
+40.7%
5,066
+17.1%
0.00%
Q2 2022$27,000
+22.7%
4,327
+62.0%
0.00%
Q1 2022$22,000
+57.1%
2,6710.0%0.00%
Q4 2021$14,000
-22.2%
2,6710.0%0.00%
Q3 2021$18,000
-21.7%
2,6710.0%0.00%
Q2 2021$23,000
-25.8%
2,671
-24.3%
0.00%
Q1 2021$31,000
-31.1%
3,528
-3.8%
0.00%
Q4 2020$45,000
+66.7%
3,669
+10.4%
0.00%
Q3 2020$27,000
-28.9%
3,322
-16.1%
0.00%
Q2 2020$38,000
+40.7%
3,959
-0.9%
0.00%
Q1 2020$27,000
-62.5%
3,993
-17.2%
0.00%
Q4 2019$72,000
+80.0%
4,822
+23.3%
0.00%
Q3 2019$40,000
-2.4%
3,9120.0%0.00%
Q2 2019$41,000
+310.0%
3,912
+327.5%
0.00%
Q1 2017$10,0000.0%9150.0%0.00%
Q4 2016$10,0009150.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 595,238$4,845,0003.97%
P.A.W. CAPITAL CORP 360,000$2,930,0003.19%
Telemetry Investments, L.L.C. 124,320$1,012,0002.20%
Soleus Capital Management, L.P. 472,558$3,847,0002.04%
Copernicus Capital Management, LLC 238,151$1,939,0001.85%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,226,0001.80%
Trellus Management Company, LLC 200,000$1,628,0001.67%
683 Capital Management, LLC 2,622,914$21,350,0001.56%
KNOTT DAVID M 275,348$2,241,0001.32%
MANGROVE PARTNERS IM, LLC 1,092,394$8,892,0001.12%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders